ScreenerHero

SCIB SciBase Holding AB (publ)

STO · SE · Healthcare · Medical Devices · scibase.com
14.80SEK-0.34%Mkt Cap: 15.22M $P/E: —

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It …

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap15.22M USD
Enterprise Value13.19M USD
Revenue (TTM)5.01M USD
Gross Profit2.59M USD
Net Income (TTM)-8.33M USD
Revenue/Share7.92 SEK
Last Price14.80 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees50
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0007045414
Valuation
P/E (Trailing)—
P/E (Forward)-92.81
PEG—
EV/EBITDA-1.45
EV/Revenue2.63
P/S3.05
P/B5.02
EPS (TTM)-14.23
EPS (Forward)-0.16
52W Range
14.401% of range54.00
52W High54.00 SEK
52W Low14.40 SEK
Profitability
Gross Margin66.99%
Oper. Margin-188.32%
EBITDA Margin-181.40%
Profit Margin-215.18%
ROE-1307.84%
ROA-166.89%
Growth
Revenue Growth74.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.09M USD
CapEx (TTM)21.81K USD
FCF Margin-122.18%
FCF Yield-40.22%
Net Debt-1.33M USD
Net Debt/EBITDA0.15
Balance Sheet
Debt/Equity3.46
Current Ratio3.21
Quick Ratio2.56
Book Value/Sh2.96 SEK
Cash/Share3.63 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJun 4, 2026
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)42.00 SEK
Upside (mean)+183.8%
Target Range42.00 SEK – 42.00 SEK
# Analysts1
Ownership
Shares Out.10.75M
Float8.42M
Insiders64.94%
Institutions11.49%
Technical
SMA 5021.23 (-30.3%)
SMA 20031.05 (-52.3%)
Beta0.01
S&P 52W Chg14.58%
Avg Vol (30d)4.61K
Avg Vol (10d)5.83K
Technical Indicators
RSI (14)22.4
MACD-1.8832
MACD Signal-2.2582
MACD Hist.+0.3750
BB Upper18.46 SEK
BB Middle16.11 SEK
BB Lower13.76 SEK
BB Width29.18%
ATR (14)0.9367 SEK
Vol Ratio (20d)0.69x